enVVeno Medical
NVNO
6 hedge funds and large institutions have $98K invested in enVVeno Medical in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and 4 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
14% less funds holding
Funds holding: 7 → 6 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
40% less capital invested
Capital invested by funds: $164K → $98K (-$66K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$49.8K |
| 2 |
LPL Financial
San Diego,
California
|
+$9.83K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$104K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$20K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$6K |
| 4 |
VF
Virtu Financial
New York
|
-$6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $56K | +$49.8K | +147 | New |
|
|
GIA
2
Gladstone Institutional Advisory
Palm Beach Gardens,
Florida
| $17K | – | – | – |
|
|
3
LPL Financial
San Diego,
California
| $11K | +$9.83K | +29 | New |
|
4
Northern Trust
Chicago,
Illinois
| $8K | – | – | – |
|
5
Osaic Holdings
Scottsdale,
Arizona
| $6K | – | – | – |
|
|
6
Renaissance Technologies
New York
| – | -$104K | -309 | Closed |
|
|
7
UBS Group
Zurich,
Switzerland
| – | -$20K | -60 | Closed |
|
|
TSS
8
Two Sigma Securities
New York
| – | -$6K | -18 | Closed |
|
|
VF
9
Virtu Financial
New York
| – | -$6K | -18 | Closed |
|
|
NFSG
10
Newbridge Financial Services Group
Boca Raton,
Florida
| – | +$339 | +1 | New |
|
NVNO Hedge Fund Activity: Q3 2020 in Review
6 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q3 2020, worth a combined $98K — down 40% from $164K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of NVNO and 3 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $49.8K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $104K sold.
- 6 institutional investors held enVVeno Medical (NVNO) as of Q3 2020, down from 7 in Q2 2020.
- Funds reported $98K of enVVeno Medical stock for Q3 2020, down 40% quarter-over-quarter.
- 3 funds opened new enVVeno Medical positions in Q3 2020 and 4 closed out, a net change of -1 holder.
- The largest enVVeno Medical buyer in Q3 2020 was Citadel Advisors, an estimated $49.8K added.
- The largest enVVeno Medical seller in Q3 2020 was Renaissance Technologies, an estimated $104K sold.
Based on aggregated 13F filings for Q3 2020.